CHINESE RESIDENTS ACCOUNT FOR 19.3% of the world’s population, yet 26.9% of all cancer-related deaths occur in China.
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks, according to a new study led by researchers at the UCLA Fielding School of Public Health.
The National Institute on Drug Abuse has awarded $5 million to researchers at UCLA to develop a resource and data center for millions of pieces of research, lab samples, statistics and other data aimed at boosting research into the effects of substance abuse on HIV/AIDS.
Delegates from China’s Academy of Chinese Medical Sciences (CACMS), located in Beijing, visited the UCLA Fielding School of Public Health on Tuesday, May 30, to sign an official memorandum of understanding (MOU) with the school. The MOU is a symbol of collaborative commitment to advance joint research and training opportunities for students and faculty of both organizations.
On January 10, 2017 UCLA’s postdoctoral scholars were honored for their important contributions to the university’s interrelated missions of research, teaching, and public service at the 2017 Postdoctoral Scholars Reception & Awards Ceremony at UCLA’s California NanoSystems Institute.
A new study from the UCLA Fielding School of Public Health suggests modifying federal health guidelines related to the use of pre-exposure prophylaxis to prevent HIV transmission because current standards could miss some people who should be on it.
Two UCLA professors have been elected to the National Academy of Medicine, among the highest honors in the fields of health and medicine.
Pre-exposure prophylaxis (PrEP) as safe as aspirin
UCLA RESEARCH ALERT
FINDINGS
Pre-exposure prophylaxis, or PrEP, is the first medicine approved by the Food and Drug Administration that has been shown to be effective for preventing HIV infection.